PI3K and cancer metabolism

被引:0
|
作者
Cantley, Lewis C. [1 ]
机构
[1] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA
关键词
D O I
10.1158/1538-7445.FBCR13-IA22
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IA22
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Targeting the PI3K signaling pathway in cancer
    Wong, Kwok-Kin
    Engelman, Jeffrey A.
    Cantley, Lewis C.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2010, 20 (01) : 87 - 90
  • [42] Development and safety of PI3K inhibitors in cancer
    Yu, Miaomiao
    Chen, Jiajia
    Xu, Zhifei
    Yang, Bo
    He, Qiaojun
    Luo, Peihua
    Yan, Hao
    Yang, Xiaochun
    ARCHIVES OF TOXICOLOGY, 2023, 97 (03) : 635 - 650
  • [43] Inhibition of PI3K as a potential treatment for cancer
    Zuluaga, S.
    Suarez-Fueyo, A.
    Carrera, A. C.
    EJC SUPPLEMENTS, 2010, 8 (05): : 61 - 61
  • [44] The role of the PI3K pathway in colorectal cancer
    Papadatos-Pastos, Dionysios
    Rabbie, Roy
    Ross, Paul
    Sarker, Debashis
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (01) : 18 - 30
  • [45] PI3K/Akt signalling pathway and cancer
    Vara, JAF
    Casado, E
    de Castro, J
    Cejas, P
    Belda-Iniesta, C
    González-Barón, M
    CANCER TREATMENT REVIEWS, 2004, 30 (02) : 193 - 204
  • [46] Inhibitors of PI3Kβ as Potential Treatment for Cancer
    Abdel-Magid, Ahmed F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (09): : 815 - 816
  • [47] PI3K signaling in cancer: beyond AKT
    Lien, Evan C.
    Dibble, Christian C.
    Toker, Alex
    CURRENT OPINION IN CELL BIOLOGY, 2017, 45 : 62 - 71
  • [48] PI3K and AKT: Unfaithful Partners in Cancer
    Faes, Seraina
    Dormond, Olivier
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (09): : 21138 - 21152
  • [49] PI3K and cancer: lessons, challenges and opportunities
    David A. Fruman
    Christian Rommel
    Nature Reviews Drug Discovery, 2014, 13 : 140 - 156
  • [50] Targeting RAS and PI3K in lung cancer
    Downward, Julian
    NATURE MEDICINE, 2008, 14 (12) : 1315 - 1316